IONS · Ionis Pharmaceuticals Inc
United States · RS rating 11 · As of 2026-10-14
| Price | 42.70 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 24 / 17 / 17 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 5 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -76.2% |
| Sales growth Q/Q | +29.7% |
| Distance from 52-week high | +50.6% |
| Market cap (USD) | $12.2B |